2017 annual financial data
Aptevo Therapeutics 2017 Net margin
Aptevo Therapeutics 2017 net margin with verified reported values.
Direct answer
Net margin was 47.57%.
Operating income was -53,949,000 USD and net income was 6,973,000 USD.
Operating cash flow was -41,573,000 USD.
Get free Aptevo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,658,000 USD
- Operating income
- -53,949,000 USD
- Net income
- 6,973,000 USD
- Operating cash flow
- -41,573,000 USD